The Role of Socioeconomic Status and Ethnicity in Influencing HPV Vaccine Knowledge and Attitudes in Adult Women

Human Papilloma Virus (HPV) Knowledge and Attitudes and the Role of (SES) Socioeconomic Status and Ethnicity



Sponsors


Source

St. Michael's Hospital, Toronto

Oversight Info

Has Dmc

No


Brief Summary

This is a survey study to assess the vaccination knowledge and attitudes of women in an inner
city Gynecology clinic. Results of this study will help determine which factors influence
vaccination knowledge and attitudes. This may help improve future vaccination tools.

Overall Status

Completed

Start Date

2008-09-01

Completion Date

2010-11-01

Primary Completion Date

2010-11-01

Study Type

Observational

Enrollment

160

Condition

 HPV

Eligibility

Study Pop

Women attending Gynecology clinic

Sampling Method

Probability Sample

Criteria

Inclusion Criteria:

- all women attending gynecology clinic

Exclusion Criteria:

Gender

Female

Minimum Age

N/A

Maximum Age

N/A

Healthy Volunteers

Accepts Healthy Volunteers


Verification Date

2016-04-01

Lastchanged Date

N/A

Firstreceived Date

N/A

Responsible Party

Responsible Party Type

Sponsor


Keywords


Has Expanded Access

No

Firstreceived Results Date

N/A

Firstreceived Results Disposition Date

N/A

Study Design Info

Observational Model

Cohort

Time Perspective

Cross-Sectional


Study First Submitted

April 14, 2010

Study First Submitted Qc

April 15, 2010

Study First Posted

April 16, 2010

Last Update Submitted

April 22, 2016

Last Update Submitted Qc

April 22, 2016

Last Update Posted

April 25, 2016


ClinicalTrials.gov processed this data on August 24, 2018

Conditions

Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov, conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Interventions

Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied. Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Study Phase

Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions that study is seeking to answer:

In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.

In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.

In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.

In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.

These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.



© 2018 ICH GCP